| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26226-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26179-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP3-26676-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-18104-500ul | |||
![Flow Cytometry: HLA G Antibody (17A5) [NBP3-26226] - Overlay Peak curve showing U937 cells stained with HLA G Antibody (17A5) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26226_rabbit-hla-g-mab-17a5-282202414183662.jpg "Flow Cytometry: HLA G Antibody (17A5) [NBP3-26226] - Overlay Peak curve showing U937 cells stained with HLA G Antibody (17A5) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")
![Flow Cytometry: KLRG1 Antibody (8E11) [NBP3-26179] - Overlay Peak curve showing A549 cells stained with KLRG1 Antibody (8E11) (red line) at 1:100. The cells were incubated in 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26179_rabbit-klrg1-mab-8e11-282202414312743.jpg "Flow Cytometry: KLRG1 Antibody (8E11) [NBP3-26179] - Overlay Peak curve showing A549 cells stained with KLRG1 Antibody (8E11) (red line) at 1:100. The cells were incubated in 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")
![ELISA: Human L-Selectin/CD62L ELISA Kit (Colorimetric) [NBP1-84821] - Standard curve](http://images.novusbio.com/fullsize/Human-L-Selectin-CD62L-ELISA-Kit-Colorimetric-ELISA-NBP1-84821-img0001.jpg "ELISA: Human L-Selectin/CD62L ELISA Kit (Colorimetric) [NBP1-84821] - Standard curve")
![Flow Cytometry: CD59 Antibody (28D4) [NBP3-26676] - Overlay Peak curve showing Hela cells stained with CD59 Antibody (28D4) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.](http://images.novusbio.com/fullsize/nbp3-26676_rabbit-cd59-mab-28d4-282202414183671.jpg "Flow Cytometry: CD59 Antibody (28D4) [NBP3-26676] - Overlay Peak curve showing Hela cells stained with CD59 Antibody (28D4) (red line) at 1:50. The cells were fixed in 4% formaldehyde and permeated by 0.2% Triton X-100. Then 10% normal goat serum to block non-specific protein-protein interactions followed by the antibody (1ug/1*10^6 cells) for 45min at 4C. The secondary antibody used was FITC-conjugated Goat Anti-rabbit IgG (H+L) at 1:200 dilution for 35min at 4C. Control antibody (green line) was rabbit IgG (1ug/1*10^6 cells) used under the same conditions. Acquisition of >10,000 events was performed.")
![ELISA: Human ICAM-2/CD102 ELISA Kit (Colorimetric) [NBP3-14631] - Example of Human ICAM-2/CD102 Standard Curve.](http://images.novusbio.com/fullsize/Human-ICAM-2-CD102-ELISA-Kit-Colorimetric-ELISA-NBP3-14631-img0001.jpg "ELISA: Human ICAM-2/CD102 ELISA Kit (Colorimetric) [NBP3-14631] - Example of Human ICAM-2/CD102 Standard Curve.")
![Flow Cytometry: Granulysin Antibody (B-L38) - Azide and BSA Free [NBP3-18104] - A typical staining pattern with the B-L38 monoclonal antibody of activated NK.](http://images.novusbio.com/fullsize/Granulysin-Antibody-B-L38-Azide-and-BSA-Free-Flow-Cytometry-NBP3-18104-img0001.jpg "Flow Cytometry: Granulysin Antibody (B-L38) - Azide and BSA Free [NBP3-18104] - A typical staining pattern with the B-L38 monoclonal antibody of activated NK.")